Chemed (CHE) Share-based Compensation (2009 - 2026)

Chemed has reported Share-based Compensation for 18 years, with the latest figure at $9.1 million in Q2 2026.

• Share-based Compensation for Q2 2026 came in at $9.1 million, down 1.77% year-over-year; the trailing twelve-month figure through Jun 2026 was $32.7 million (up 0.68% YoY), and the FY2025 annual result was $32.7 million, up 1.99% from the prior year.
• Share-based Compensation slipped to $9.1 million in Q2 2026, from $9.2 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $9.2 million in Q1 2026 and troughed at $4.7 million in Q3 2022.
• A 5-year average of $7.7 million and a median of $8.2 million in 2024 frame the typical range for Share-based Compensation.
• The widest annual swing landed in 2022, when Share-based Compensation rose 25.89%; it then dropped 1.77% in 2026.
• A 5-year view of Share-based Compensation shows it stood at $6.9 million in 2022, then climbed by 11.5% to $7.7 million in 2023, then climbed by 5.11% to $8.1 million in 2024, then gained by 2.43% to $8.3 million in 2025, then advanced by 9.11% to $9.1 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $9.1 million in Q2 2026, $9.2 million in Q1 2026, and $8.3 million in Q4 2025.